Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Tria Beauty, Inc.
DUBLIN, Calif., Dec. 16, 2013 /PRNewswire/ -- Tria Beauty, Inc., which develops and markets light-based consumer skincare products, today announced that it has entered into a comprehensive settlement agreement with Cynosure, Inc. that ends the patent infringement litigation between Tria and Palomar Medical Technologies, which Cynosure acquired in June 2013.
"We are pleased to have executed this settlement agreement with Cynosure so we can continue our focus on delivering breakthrough skincare devices directly to consumers that provide transformative benefits not available outside of a physician's office, without the distraction and expense of litigation," said Tria Beauty's President and CEO, Kevin Appelbaum.
The settlement includes two non-exclusive patent license agreements between Cynosure and Tria:
About Tria Beauty, Inc.
Tria Beauty uses light to transform skin care, liberating women from endless and ineffective beauty regimens. Tria's devices use the same technologies preferred by dermatologists for in-office treatments to deliver professional results in the privacy and comfort of home and at a fraction of the cost. Tria's portfolio of medical devices for home-use includes the popular Hair Removal Laser 4X, newly introduced Hair Removal Laser Precision, Skin Perfecting Blue Light used to clear acne blemishes and prevent future breakouts, and Age-Defying Laser for treating multiple signs of facial aging. Learn more about Tria Beauty's devices and other skin care products by visiting www.triabeauty.com.
©2012 PR Newswire. All Rights Reserved.